Guillain-Barré Syndrome (42 Cases) Occurring during a Zika Virus Outbreak in French Polynesia

Medicine (United States)

Volumn 95, Issue 14, 2016, Pages

  Watrin, Louise ^a   Ghawché, Frédéric ^b   Larre, Philippe ^b   Neau, Jean Philippe ^a   Mathis, Stéphane ^a   Fournier, Emmanuel ^c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Taaone Hospital   (French Polynesia)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNOGLOBULIN;

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEEP TENDON REFLEX; DISEASE DURATION; DYSPHAGIA; FACIAL NERVE PARALYSIS; FEMALE; FRENCH POLYNESIA; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; LIMB WEAKNESS; LUMBAR PUNCTURE; MALE; MEDIAN NERVE; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERONEUS NERVE; PLASMAPHERESIS; PRIORITY JOURNAL; RADIAL NERVE; SENSORY SYSTEM ELECTROPHYSIOLOGY; SEX RATIO; SURAL NERVE; TENDON REFLEX; TRACHEOTOMY; ULNAR NERVE; WALKING; ZIKA FEVER; ZIKA VIRUS; COMPLICATION; ELECTROPHYSIOLOGY; EPIDEMIC; EPIDEMIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; POLYNESIA; RETROSPECTIVE STUDY; VIROLOGY;

ADULT; AGED; DISEASE OUTBREAKS; ELECTROPHYSIOLOGICAL PHENOMENA; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; MIDDLE AGED; POLYNESIA; RETROSPECTIVE STUDIES; ZIKA VIRUS INFECTION;

EID: 84964689174     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003257     Document Type: Article

References (41)

1. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012;366:2294-2304.
2. Verity C, Stellitano L, Winstone AM, et al. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome. Arch Dis Child. 2014;99:532-538.
3. Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr. 2010;28:545-552.
4. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet. 2008;371:500-509.
5. Dourado ME, Felix RH, da Silva WK, et al. Clinical characteristics of Guillain-Barré syndrome in a tropical country: a Brazilian experience. Acta Neurol Scand. 2012;125:47-53.
6. Oehler E, Le Henaff O, Ghawche F. Manifestations neurologiques de la dengue. Presse Med. 2012;41:e547-e552.
7. Asnis DS, Conetta R, Teixeira AA, et al. The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis. 2000;30:413-418.
8. Ravi V, Taly AB, Shankar SK, et al. Association of Japanese encephalitis virus infection with Guillain-Barre syndrome in endemic areas of south India. Acta Neurol Scand. 1994;90:67-72.
9. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res. 2010;85:328-345.
10. Dick GW, Kitchen SF, Haddow AJ. Zika virus I isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46:509-520.
11. Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15:1347-1350.
12. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360:2536-2543.
13. Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spreading of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 2014;20:O595-O596.
14. Cao-Lormeau VM, Roche C, Teissier A, et al. Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis. 2014;20:1084-1086.
15. Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barré syndrome-case report, French Polynesia, December 2013. Euro Surveill. 2014:19pii: 20720.
16. ECDC. Rapid assessment: Zika infection outbreak, French Polynesia In Stockholm: European Centre for Disease prevention and Control (ECDC). 2014; doi:http://ecdc.europa.eu/en/publications/Publications/zika-virus-rapid-risk-Assessment-23-february-2016.pdf.
17. Fokke C, van den Berg B, Drenthen J, et al. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137:33-43.
18. Sejvar JJ, Pfeifer D, Schonberger LB. Guillain-Barre syndrome following influenza vaccination: causal or coincidental? Curr Infect Dis Rep. 2011;13:387-398.
19. Halstead SB, Udomsakdi S, Singharaj P, et al. Dengue chikungunya virus infection in man in Thailand, 1962-1964. 3. Clinical, epidemiologic, and virologic observations on disease in non-indigenous white persons. Am J Trop Med Hyg. 1969;18:984-996.
20. Yap State Department of Health Services. Plaquette Zika Virus. August 9th 2007; doi: https://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source =web&cd=1&ved 0ahUKEwjzpuD5jNnLAhVI1BoKHWmkBowQFggc MAA&url=http%3A%2F%2Fwww.invs.sante.fr%2Fcontent%2 Fdownload%2F83617%2F305876%2Fversion%2F10%2Ffile%2FZika %2B2014%2Bnote%2B-%2Bpolynesie%2Bet%2Bmicronesie-revue% 2BSI%2BVf2.pdf&usg=AFQjCNEQs7 PF9YuwE1aXvHAPH6y FGSHsA&bvm=bv.117604692, d.ZWU&cad=rja.
21. Fournier E. Examen électromyographique Sémiologie électrophysio-logique des nerfs et muscles. 2nd ed (858 pages). Cachan (France): Editions Médicales Internationales; 2008.
22. Kimura J. Nerve conduction studies and needle electromyography. Peripheral neuropathy 4th ed.Edited by Dyck P, Thomas P, eds. Philadelphia: Elsevier Saunders; 2005:899-970.
23. Isose S, Kuwabara S, Kokubun N, et al. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst. 2009;14: 151-158.
24. Kuwabara S, Ogawara K, Misawa S, et al. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 2002;72:37-42.
25. Shahani BT, Young RR, Potts F, et al. Terminal latency index (TLI) and late response studies in motor neuron disease (MND), peripheral neuropathies and entrapment syndromes. Acta Neurol Scand. 1979;73(Suppl):118.
26. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Mi-cronesia, 2007. Emerg Infect Dis. 2008;14:1232-1239.
27. Schmidt-Chanasit J, Emmerich P, Tappe D, et al. Autochthonous dengue virus infection in Japan imported into Germany, September 2013. Euro Surveill. 2014:19.
28. Kokubun N, Shahrizaila N, Hirata K, et al. Reversible conduction failure is distinct from neurophysiological patterns of recovery in mild demyelinating Guillain-Barré syndrome. J Neurol Sci. 2013;326:111-114.
29. Uncini A, Kuwabara S. Electrodiagnostic criteria for Guillain-Barré syndrome: a critical revision and the need for an update. Clin Neurophysiol. 2012;123:1487-1495.
30. Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 2013;12:1180-1188.
31. Uncini A, Kuwabara S. Reply to "Serial electrodiagnostic studies increase the diagnostic yield of axonal Guillain-Barré syndrome". Clin Neurophysiol. 2013;124:212-213.
32. Dick GW. Zika virus II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg. 1952;46:521-534.
33. Thorsby E. The Polynesian gene pool: an early contribution by Amerindians to Easter Island. Philos Trans R Soc Lond B Biol Sci. 2012;367:812-819.
34. Edinur HA, Dunn PP, Hammond L, et al. HLA and MICA polymorphism in Polynesians and New Zealand Maori: implications for ancestry and health. Hum Immunol. 2013;74:1119-1129.
35. Jin PP, Sun LL, Ding BJ, et al. Human leukocyte antigen DQB1 (HLA-DQB1) polymorphisms and the risk for Guillain-Barré syndrome: a systematic review and meta-Analysis. PLoS One. 2015;10:e0131374.
36. ECDC, Zika virus disease epidemic: potential association with microcephaly and Guillain-Barré (first update) In 21 January 2016: European Center for disease prevention and control, 2016; doi: http://ecdc.europa.eu/en/publications/Publications/rapid-risk-Assess-ment-zika-virus-first-update-jan-2016.pdf
37. Faye O, Freire CC, Iamarino A, et al. Molecular evolution of Zika virus during its emergence in the 20(th century. PLoS Negl Trop Dis. 2014;8:e2636.
38. Baronti C, Piorkowski G, Charrel RN, et al. Complete coding sequence of zika virus from a French polynesia outbreak in 2013. Genome Announc. 2014:2e00500-14.
39. Enfissi A, Codrington J, Roosblad J, et al. Zika virus genome from the Americas. Lancet. 2016:00003-9pii: S0140-6736 (16).
40. Carod-Artal FJ, Wichmann O, Farrar J, et al. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906-919.
41. Wong PS, Li MZ, Chong CS, et al. (Stegomyia) albopictus (Skuse): a potential vector of Zika virus in Singapore. PLoS Negl Trop Dis. 2013;7:e2348.